Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions

被引：0
作者：
C. Biagi
V. Conti
N. Montanaro
M. Melis
E. Buccellato
M. Donati
A. Covezzoli
R. Amato
L. Pazzi
M. Venegoni
A. Vaccheri
D. Motola
机构：
[1] University of Bologna,Unit of Pharmacology, Department of Medical and Surgical Sciences
[2] Pharmacovigilance Regional Centre of Lombardy,Health Care Systems Department
[3] CINECA - Interuniversity Consortium,undefined
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Bevacizumab; Ranibizumab; Pegaptanib; Intravitreal use; Safety profile; Spontaneous reporting database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1505 / 1512
页数：7
相关论文
共 11 条
  • [1] Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
    Biagi, C.
    Conti, V.
    Montanaro, N.
    Melis, M.
    Buccellato, E.
    Donati, M.
    Covezzoli, A.
    Amato, R.
    Pazzi, L.
    Venegoni, M.
    Vaccheri, A.
    Motola, D.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (12) : 1505 - 1512
  • [2] Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions
    Bonaldo, Giulia
    Andriani, Luisa Anna
    D'Annibali, Ottavio
    Motola, Domenico
    Vaccheri, Alberto
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (11) : 1457 - 1463
  • [3] Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database
    Micieli, Jonathan A.
    Micieli, Andrew
    Smith, Andrew F.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2010, 45 (03): : 231 - 238
  • [4] Cardiovascular and Cerebrovascular Safety of Ranibizumab, Bevacizumab, and Aflibercept in Ocular Diseases: An Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Zeng, Yanbin
    Guo, Xiaohui
    Xiao, Fengjiao
    Zhang, Haixia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (08) : 909 - 917
  • [5] A pharmacovigilance study of adverse event profiles and haemorrhagic safety of bevacizumab based on the FAERS database
    Tang, Linlin
    Ding, Chuanhua
    Li, Hongying
    Yin, Guoqiang
    Zhang, Haixia
    Liu, Wen Shan
    Ji, Yinghui
    Li, Hui
    EXPERT OPINION ON DRUG SAFETY, 2023, : 213 - 220
  • [6] A pharmacovigilance study of adverse event profiles and haemorrhagic safety of bevacizumab based on the FAERS database
    Tang, Linlin
    Ding, Chuanhua
    Li, Hongying
    Yin, Guoqiang
    Zhang, Haixia
    Liu, Wen Shan
    Ji, Yinghui
    Li, Hui
    EXPERT OPINION ON DRUG SAFETY, 2023,
  • [7] Central Nervous System Ischemia Associated with Bevacizumab: An Analysis of the Japanese Adverse Drug Event Report Database
    Sugimoto, Shohei
    Ishida, Tomoaki
    Kawada, Kei
    Jobu, Kohei
    Morisawa, Shumpei
    Tamura, Naohisa
    Takuma, Daisuke
    Yoshioka, Saburo
    Miyamuraa, Mitsuhiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (12) : 1805 - 1811
  • [8] Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies
    Plyukhova, Anna A.
    Budzinskaya, Maria V.
    Starostin, Kirill M.
    Rejdak, Robert
    Bucolo, Claudio
    Reibaldi, Michele
    Toro, Mario D.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [9] Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database
    Nikitina, Victoria
    Laurini, Greta Santi
    Montanaro, Nicola
    Motola, Domenico
    CANCERS, 2023, 15 (14)
  • [10] A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis
    Singh, Rishi P.
    Srivastava, Sunil K.
    Ehlers, Justis P.
    Silva, Fabiana Q.
    Bedi, Rumneek
    Schachat, Andrew P.
    Kaiser, Peter K.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 1759 - 1766
12